Received Mar 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | UNK | 3CA20C1 | IM / LL |
expired DAPTACEL given to a patient, with no reported adverse event; Initial information received on 10-Mar-2026 regarding an unsolicited valid non-serious case received from a nurse. This case involves a patient of unknown age and unknown gender who received expired Diphtheria-15/Tetanus/5 AC Pertussis Vaccine [Daptacel], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. Concomitant medication(s) included Influenza vaccine. On 10-Mar-2026, the patient received expired 0.5ml dose of Diphtheria-15/Tetanus/5 AC Pertussis Vaccine, Suspension for injection (strength: standard) batch number 3CA20C1 and expiry date 28-Feb-2026 via intramuscular route in left thigh for immunization, with no reported adverse event [Expired product administered] (Latency: same day). Action taken: Not reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Influenza vaccine